American Funds®

  • Forms
  • MY ACCOUNTS
  • INVESTMENTS
  • INSIGHTS
  • PRODUCTS
  • PLANNING
  • SERVICE & SUPPORT

GROWTH FUNDS

®

All Holdings

BACK TO FUND'S DETAIL PAGE
No holdings data is available at this time.
245 Total Holdings:
As of 12/31/15 (updated quarterly, upon availability).
All Holdings: 1 - 15 of 245
Asset Type
Amgen Inc. Equity 8,398,080 $1,363,260,326.00 2.93%
Alexion Pharmaceuticals, Inc. Equity 5,906,898 $1,126,740,794.00 2.42%
Netflix, Inc. Equity 9,520,000 $1,088,897,600.00 2.34%
Oracle Corp. Equity 29,141,000 $1,064,520,730.00 2.29%
UnitedHealth Group Inc. Equity 7,839,806 $922,274,778.00 1.98%
Alphabet Inc., Class C Equity 1,144,826 $868,785,555.00 1.87%
Accenture PLC, Class A Equity 7,858,300 $821,192,350.00 1.77%
Amazon.com, Inc. Equity 1,085,000 $733,340,650.00 1.58%
Progressive Corp. Equity 22,730,255 $722,822,109.00 1.55%
Avago Technologies Ltd. Equity 4,903,195 $711,698,754.00 1.53%
Monsanto Co. Equity 7,072,600 $696,792,552.00 1.5%
Stryker Corp. Equity 7,233,552 $672,286,323.00 1.45%
BioMarin Pharmaceutical Inc. Equity 6,434,714 $674,100,639.00 1.45%
Union Pacific Corp. Equity 8,534,060 $667,363,492.00 1.44%
Texas Instruments Inc. Equity 10,667,000 $584,658,270.00 1.26%
All Holdings: 1 - 15 of 245

Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value.

Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectuses and summary prospectuses, which can be obtained from a financial professional and should be read carefully before investing.

  1. Excludes certain securities in initial period of acquisition.

For more information about the risks associated with each fund, go to its detailed fund information page or read the prospectus.